Decreased nuclear expression and increased cytoplasmic expression of ING5 may be linked to tumorigenesis and progression in human head and neck squamous cell carcinoma

Journal of Cancer Research and Clinical Oncology

Volumn 136, Issue 10, 2010, Pages 1573-1583

  Li, Xiaohan ^a,b   Nishida, Takeshi ^a   Noguchi, Akira ^a   Zheng, Yang ^a   Takahashi, Hiroyuki ^a   Yang, Xianghong ^b   Masuda, Shinji ^c   Takano, Yasuo ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b CHINA MEDICAL UNIVERSITY   (China)

^c Kouseiren Takaoka Hospital   (Japan)

Author keywords

HNSCC; ING5; P53; Tumorigenesis

Indexed keywords

CYCLINE; INHIBITOR OF GROWTH PROTEIN 5; ONCOPROTEIN; PROTEIN P21; PROTEIN P300; UNCLASSIFIED DRUG;

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CELL CYCLE ARREST; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE MUTATION; HEAD AND NECK CARCINOMA; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SQUAMOUS CELL CARCINOMA; TISSUE MICROARRAY; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL NUCLEUS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYTOPLASM; DISEASE PROGRESSION; E1A-ASSOCIATED P300 PROTEIN; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 77956060393     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-010-0815-x     Document Type: Article

References (27)

1. T Abbas A Dutta 2009 p21 in cancer: intricate networks and multiple activities Nat Rev Cancer 9 400 414 10.1038/nrc2657 1:CAS:528: DC%2BD1MXlvFShsb4%3D 19440234
2. Barnes L, Eveson JW, Reichart P, Sidransky D (2005) World Health Organization classification of tumours: pathology and genetics of head and neck tumours, 3rd edn. IARC Press, Lyon, pp 109-110
3. SS Borkosky M Gunduz H Nagatsuka LB Beder E Gunduz MA Ali AP Rodriguez MZ Cilek S Tominaga N Yamanaka K Shimizu N Nagai 2009 Frequent deletion of ING2 locus at 4q35.1 associates with advanced tumor stage in head and neck squamous cell carcinoma J Cancer Res Clin Oncol 135 703 713 10.1007/s00432-008-0507-y 1:CAS:528:DC%2BD1MXjvVagtLk%3D 18998165
4. B Cengiz M Gunduz H Nagatsuka L Beder E Gunduz R Tamamura N Mahmut K Fukushima MA Ali Y Naomoto K Shimizu N Nagai 2007 Fine deletion mapping of chromosome 2q21-37 shows three preferentially deleted regions in oral cancer Oral Oncol 43 241 247 10.1016/j.oraloncology.2006.03.004 1:CAS:528: DC%2BD2sXhvVyrsrc%3D 16857411
5. KS Champagne N Saksouk PV Peña K Johnson M Ullah XJ Yang J Côté TG Kutateladze 2008 The crystal structure of the ING5 PHD finger in complex with an H3K4me3 histone peptide Proteins 72 1371 1376 10.1002/prot.22140 1:CAS:528:DC%2BD1cXhtFCrtb3P 18623064
6. Y Doyon C Cayrou M Ullah AJ Landry V Côté W Selleck WS Lane S Tan XJ Yang J Côté 2006 ING tumor suppressor proteins are critical regulators of chromatin acetylation required for genome expression and perpetuation Mol Cell 21 51 64 10.1016/j.molcel.2005.12.007 1:CAS:528: DC%2BD28Xptlelsw%3D%3D 16387653
7. M Fabbro BR Henderson 2003 Regulation of tumor suppressors by nuclear-cytoplasmic shuttling Exp Cell Res 282 59 69 10.1016/S0014-4827(02) 00019-8 1:CAS:528:DC%2BD3sXjtFCgsA%3D%3D 12531692
8. W Gong K Suzuki M Russell K Riabowol 2005 Function of the ING family of PHD proteins in cancer Int J Biochem Cell Biol 37 1054 1065 10.1016/j.biocel. 2004.09.008 1:CAS:528:DC%2BD2MXhvVCqu74%3D 15743678
9. M Gunduz M Ouchida K Fukushima H Hanafusa T Etani S Nishioka K Nishizaki K Shimizu 2000 Genomic structure of the human ING1 gene and tumor-specific mutations detected in head and neck squamous cell carcinomas Cancer Res 60 3143 3146 1:CAS:528:DC%2BD3cXktlyktb8%3D 10866301
10. M Gunduz M Ouchida K Fukushima S Ito Y Jitsumori T Nakashima N Nagai K Nishizaki K Shimizu 2002 Allelic loss and reduced expression of the ING3, a candidate tumor suppressor gene at 7q31, in human head and neck cancers Oncogene 21 4462 4470 10.1038/sj.onc.1205540 1:CAS:528:DC%2BD38XkslKntL8%3D 12080476
11. M Gunduz H Nagatsuka K Demircan E Gunduz B Cengiz M Ouchida H Tsujigiwa E Yamachika K Fukushima L Beder S Hirohata Y Ninomiya K Nishizaki K Shimizu N Nagai 2005 Frequent deletion and down-regulation of ING4, a candidate tumor suppressor gene at 12p13, in head and neck squamous cell carcinomas Gene 356 109 117 10.1016/j.gene.2005.02.014 1:CAS:528:DC%2BD2MXot1Wmtbc%3D 15935570
12. Y Hara Z Zheng SC Evans D Malatjalian DC Riddell DL Guernsey LD Wang K Riabowol AG Casson 2003 ING1 and p53 tumor suppressor gene alterations in adenocarcinomas of the esophagogastric junction Cancer Lett 192 109 116 10.1016/S0304-3835(02)00635-3 1:CAS:528:DC%2BD3sXhvFWqtbs%3D 12637159
13. SL Harris AJ Levine 2005 The p53 pathway: positive and negative feedback loops Oncogene 24 2899 2908 10.1038/sj.onc.1208615 1:CAS:528: DC%2BD2MXjtlehs7c%3D 15838523
14. GH He CC Helbing MJ Wagner CW Sensen K Riabowol 2005 Phylogenetic analysis of the ING family of PHD finger proteins Mol Biol Evol 22 104 116 10.1093/molbev/msh256 1:CAS:528:DC%2BD2cXhtFansrbJ 15356280
15. NG Iyer H Ozdag C Caldas 2004 p300/CBP and cancer Oncogene 23 4225 4231 10.1038/sj.onc.1207118 1:CAS:528:DC%2BD2cXkvVChtrc%3D 15156177
16. K Kameyama CL Huang D Liu D Masuya T Nakashima S Sumitomo Y Takami M Kinoshita H Yokomise 2003 Reduced ING1b gene expression plays an important role in carcinogenesis of non-small cell lung cancer patients Clin Cancer Res 9 4926 4934 1:CAS:528:DC%2BD3sXosVGjtLo%3D 14581367
17. T Kumada K Tsuneyama H Hatta S Ishizawa Y Takano 2004 Improved 1-h rapid immunostaining method using intermittent microwave irradiation: practicability based on 5 years application in Toyama Medical and Pharmaceutical University Hospital Mod Pathol 17 1141 1149 10.1038/modpathol.3800165 15167936
18. GS Nouman JJ Anderson S Crosier J Shrimankar J Lunec B Angus 2003 Downregulation of nuclear expression of the p33(ING1b) inhibitor of growth protein in invasive carcinoma of the breast J Clin Pathol 56 507 511 10.1136/jcp.56.7.507 1:STN:280:DC%2BD3szjtFOntQ%3D%3D 12835295
19. PV PPeña F Davrazou X Shi KL Walter VV Verkhusha O Gozani R Zhao TG Kutateladze 2006 Molecular mechanism of histone H3K4me3 recognition by plant homeodomain of ING2 Nature 442 31 32 10.1038/442031a
20. M Russell P Berardi W Gong K Riabowol 2006 Grow-ING, Age-ING and Die-ING: ING proteins link cancer, senescence and apoptosis Exp Cell Res 312 951 961 10.1016/j.yexcr.2006.01.020 1:CAS:528:DC%2BD28XivV2rtLc%3D 16516887
21. M Shiseki M Nagashima RM Pedeux M Kitahama-Shiseki K Miura S Okamura H Onogi Y Higashimoto E Appella J Yokota CC Harris 2003 p29ING4 and p28ING5 bind to p53 and p300, and enhance p53 activity Cancer Res 63 2373 2378 1:CAS:528:DC%2BD3sXjslehsrg%3D 12750254
22. T Soussi G Lozano 2005 p53 mutation heterogeneity in cancer Biochem Biophys Res Commun 331 834 842 10.1016/j.bbrc.2005.03.190 1:CAS:528: DC%2BD2MXjslKjtLg%3D 15865939
23. T Soussi KG Wiman 2007 Shaping genetic alterations in human cancer: the p53 mutation paradigm Cancer Cell 12 303 312 10.1016/j.ccr.2007.10.001 1:CAS:528:DC%2BD2sXht1ais7zN 17936556
24. T Toyama H Iwase P Watson H Muzik E Saettler A Magliocco L DiFrancesco P Forsyth I Garkavtsev S Kobayashi K Riabowol 1999 Suppression of ING1 expression in sporadic breast cancer Oncogene 18 5187 5193 10.1038/sj.onc.1202905 1:CAS:528:DyaK1MXmsVyhurk%3D 10498868
25. M Unoki K Kumamoto S Takenoshita CC Harris 2009 Reviewing the current classification of inhibitor of growth family proteins Cancer Sci 100 1173 1179 10.1111/j.1349-7006.2009.01183.x 1:CAS:528:DC%2BD1MXosl2ktLw%3D 19432890
26. L Weisz M Oren V Rotter 2007 Transcription regulation by mutant p53 Oncogene 26 2202 2211 10.1038/sj.onc.1210294 1:CAS:528:DC%2BD2sXjs1yqt7k%3D 17401429
27. D Ythier D Larrieu C Brambilla E Brambilla R Pedeux 2008 The new tumor suppressor genes ING: genomic structure and status in cancer Int J Cancer 123 1483 1490 10.1002/ijc.23790 1:CAS:528:DC%2BD1cXhtV2ru77O 18636562